AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.984
-0.056 (-5.35%)
At close: Apr 28, 2026, 4:00 PM EDT
0.984
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $24.94 million as of April 28, 2026. Its market cap has increased by 478.42% in one year.
Market Cap
24.94M
Enterprise Value
59.05M
1-Year Change
478.42%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $24.94M, a decrease of -60.83%. That is a compound annual growth rate of -16.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 26.32M | 102.08% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 28.09M |
| Polyrizon | 27.74M |
| Lantern Pharma | 27.57M |
| Longeveron | 27.52M |
| NanoViricides | 27.21M |
| Neuphoria Therapeutics | 27.17M |
| NeuroSense Therapeutics | 26.52M |
| ABVC BioPharma | 26.44M |